Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study the Safety and Efficacy of Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Acute Cerebral Infarction

NCT03186456 is registered in ClinicalTrials.gov with Sclnow Biotechnology Co., Ltd. as lead sponsor.

NCT NCT03186456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03186456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study the Safety and Efficacy of Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Acute Cerebral Infarction
Lead sponsor
Sclnow Biotechnology Co., Ltd.
Phase
Phase 1
Overall status
Suspended
Start date
December 31, 2026
Completion date
December 31, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral infarction